Showing 1 - 5 results of 5 for search 'van Weely, S', query time: 0.02s
Refine Results
-
1
Sustained therapeutic effects of oral miglustat (Zavesca, N-butyldeoxynojirimycin, OGT 918) in type I Gaucher disease. by Elstein, D, Hollak, C, Aerts, J, van Weely, S, Maas, M, Cox, T, Lachmann, R, Hrebicek, M, Platt, F, Butters, T, Dwek, R, Zimran, A
Published 2004Journal article -
2
Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis. by Cox, T, Lachmann, R, Hollak, C, Aerts, J, van Weely, S, Hrebícek, M, Platt, F, Butters, T, Dwek, R, Moyses, C, Gow, I, Elstein, D, Zimran, A
Published 2000Journal article -
3
The Extent and Nature of Functional Limitations According to the Health Assessment Questionnaire Disability Index in Patients with Rheumatoid Arthritis and Severe Functional Disabi... by Max M. H. Teuwen, Maria A. T. van Wissen, Wilfred F. Peter, Dirkjan van Schaardenburg, Cornelia H. M. van den Ende, Maaike G. J. Gademan, Salima F. E. van Weely
Published 2024-01-01
Article -
4
Inhibition of substrate synthesis as a strategy for glycolipid lysosomal storage disease therapy. by Platt, F, Jeyakumar, M, Andersson, U, Priestman, D, Dwek, R, Butters, T, Cox, T, Lachmann, R, Hollak, C, Aerts, J, Van Weely, S, Hrebícek, M, Moyses, C, Gow, I, Elstein, D, Zimran, A
Published 2001Journal article -
5
Effectiveness and cost-effectiveness of a multimodal, physiotherapist-led, vocational intervention in people with inflammatory arthritis: study protocol of the Physiotherapy WORKs... by N. F. Bakker, S. F. E. van Weely, N. Hutting, Y. F. Heerkens, J. A. Engels, J. B. Staal, M. van der Leeden, A. Boonen, W. B. van den Hout, T. P. M. Vliet Vlieland, J. Knoop
Published 2023-09-01
Article